1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Endomyocardial Fibrosis: new trials by email Literature Review of Endomyocardial Fibrosis trials Research Report on Endomyocardial Fibrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Spironolactone in Adult Congenital Heart Disease Spironolactone 25mg, Placebo - Congenital Heart Disease, Heart Failure | Phase 2 | Completed | Oregon Health and Science University | 40 | 2010-02-01 | 2019-08-21 |
Heart Defects, Congenital (1) · Heart Failure (1)
Cardiomyopathies (1) · Cardiovascular Abnormalities (1) · Cardiovascular Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Heart Diseases (1)
Spironolactone (1)
Oregon Health and Science University (1)
United States (1)
K23HL093024 (1)